Scientists discover how SARS-CoV-2 activates platelets
In a recent study published in the Blood Advances journal, the researchers assessed the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on platelet...
Angiotensin-Converting Enzyme 2
-
-
The challenges of Omicron
The coronavirus disease 2019 (COVID-19) pandemic broke out early in 2020, following the reporting of several cases of pneumonia caused by the severe acute respiratory...
-
Marine resources could be promising drug candidates against SARS-CoV-2 Omicron
A recent review paper, published in the MDPI’s specialized journal COVID, highlights key features of the Omicron variant of the severe acute respiratory syndrome coronavirus...
-
Impact of binding antibody titers and RBD-ACE2 interaction inhibition titers on Omicron breakthrough infections
In a recent study posted to the medRxiv* preprint server, the researchers investigated the effect of binding antibodies on severe acute respiratory syndrome coronavirus 2...
-
Antibody-based treatment, endogenous immune responses, and within-host SARS-CoV-2 evolution in immunocompromised patients
In a recent study posted to the medRxiv* preprint server, researchers investigated the interplay of all the factors responsible for within-host evolution of severe acute...
-
Study evaluates the ocular tropism and the possible ocular transmission of SARS-CoV-2 in animal models
In a recent study posted to the bioRxiv* preprint server, researchers demonstrated ocular tropism of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) through neuronal invasion...
-
Study identifies Etravirine and Dolutegravir as effective entry inhibitors of wild-type and predominant variants of SARS-CoV-2
In a recent study published in the International Journal of Molecular Sciences, researchers identified drugs inhibiting the entry of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)....
-
SARS-CoV-2 infection patterns in olfactory epithelium
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) readily transmits in close contact through respiratory droplets. The nasal cavity is the primary site of viral...
-
SARS-CoV-2 RBD is a selective integrin agonist
In a recent study published on the bioRxiv* preprint server, researchers assess the Arg-Gly-Asp (RGD) motif-mediated binding of the receptor-binding domain (RBD) of the severe...
-
Role of cGAS-STING in SARS-CoV-2 infection
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that led to the coronavirus disease 2019 (COVID-19) pandemic can cause various clinical presentations ranging...
-
Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection
Since the onset of the Coronavirus Disease 2019 (COVID-19) pandemic, it has brought about episodic waves of increased infections due to the emergence of new severe...
-
Structural differences between SARS-CoV-1 and SARS-CoV-2 RBDs
The genome of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is about 80% similar to that of SARS-CoV. This high degree of similarity shared...